A proton beam therapy clinic in Poland.
Private proton centres are targeting patients who might not see the most benefit from expensive treatments.
Up to 20 per cent of women have pain during sexual intercourse and up to 40 per cent have issues with bladder control. Physiotherapy can help.
A step-by- step coordinated physiotherapy plan is key for patients with disorders related to the pelvic floor.
Early detection of disease can be a double-edged sword.
The threshold for diagnosing common conditions such as high blood pressure, chronic kidney disease and gestational diabetes have all lowered in recent years. But for whose benefit?
Providing tools to help African-American men with prostate cancer make decisions about care can make a big difference.
Prostate cancer outcomes have differed between black men and other ethnic groups for decades. Could improving the way doctors talk and share information with black patients make a difference?
Many people associate the word cancer with major illness or death.
Labelling very low-risk conditions as cancers can cause unnecessary anxiety and lead to overtreatment.
A blood test can reveal whether the level of a protein produced by prostate cells is elevated.
Prostate cancer is the second deadliest cancer among men, but not all types of the disease are as deadly as others. That has led to confusion over screening. An expert explains why new guidelines make sense.
Most doctors and nurses agree exercise is beneficial but don’t routinely prescribe exercise as part of their patients’ cancer treatment plan.
Photo credit: Exercise Oncology Team at Australian Catholic University
Historically the advice to cancer patients was to rest and avoid activity. We now know this advice may be harmful to patients, and that every person with cancer would benefit from exercise medicine.
Prostate cancer cell, viewed with a scanning electron microscope.
Cancer doesn't just grow uncontrollably. It has a smarter strategy than that.
Many men who have prostate cancer will die with it, rather than of it.
Since the 1980s, PSA tests have been used for the diagnosis and follow-up of prostate cancer. However, its use as a screening test for prostate cancer remains controversial.
Liquid biopsy is less invasive than standard biopsy, where a needle is put into a solid tumour to confirm a cancer diagnosis.
There are currently few effective and non-invasive methods to screen for early stages of cancer. But scientists have now developed a new blood test that promises to detect eight different cancers.
Even if they are not treated, only about three per cent of men will die of prostate cancer over their lifetime, most in their 70s or 80s.
A family physician and public health researcher explains why he isn't getting a prostate cancer test in Movember or at any time in the near future.
Basic anatomical knowledge can save lives.
Patients need to be at the centre of consultations about their treatment.
Men diagnosed with prostate cancer should be given all their options for treatment before they make a decision. In Australia today, this isn't the rule, but the exception.
Some conditions should be classified as normal in some people and don’t need treatment.
Australian health-care organisations are urging action on treatments of people who don't need them.
Two new studies are bursting the bubble about the value of screening men for prostate cancer.
Two major studies cast doubt on the value of screening for prostate cancer, yet it continues regardless.
Surgery to remove early-stage prostate cancer has serious side-effects including incontinence and impotence.
Many men live with prostate cancer rather than die from it. Here's the evidence for why they shouldn't jump to surgery.
The modern medical system is built on a one-on-one relationship between patient and physician.
(AP Photo/Jeff Barnard, File)
Cancer care is often impersonal, industrial and needlessly stressful. Allowing patients to witness personal introductions between their physicians would help ease their anxiety and build trust.
Digitized strand of DNA.
Genetic testing is revealing important information about disease risks, and consumers can now pay for a test to know their risk. They might be better off if their doctors considered these risks, too.
Tumour evolution was first identified 40 years ago. We're finally making good progress with it.
Radiotherapy treats cancer by directing beams of high energy x-rays at the tumour.
Getting the right amount of radiation is a fine balance between therapy and harm. A common way to improve the benefit-to-cure ratio is to fire multiple beams at the tumour from different directions.